Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New Digital Resource Launched to Support Health, Social Care and Industry Innovation
Achieving Innovation is a new resource developed by Life Sciences Hub Wales to inform and […]
NHS Investment Boost to Ambulance Staff Numbers Ahead of Winter
Ambulance Trusts in England will be given an extra £55 million to boost staff numbers […]
‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis
‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]
NHS Mental Health Crisis Helplines Receive Three Million Calls
Mental health helplines run by the NHS have answered around three million calls during the […]
Waits For Treatment Drop As NHS Bounces Back
The number of people waiting longer than 18 and 52 weeks to begin non-urgent treatment […]
Researchers Behind Lifesaving Astra-Zeneca Jab Named Winners Of NHS Gong
Research teams at Oxford University who joined forces to fight coronavirus by developing a covid […]
NHS Chief Hails ‘Unprecedented’ Honour For Staff
Sir Simon Stevens today hailed the “skill and compassion and the fortitude” of health service […]
SCAS CPR Resuscitation and Defibrillator App Save a Life Sees Spike in Downloads
An ambulance service app which provides cardiopulmonary resuscitation (CPR) guidance and locates the nearest defibrillator […]
New Services Launched to Help People Achieve a Healthier Weight and Improve Wellbeing
Thousands of adults and children will benefit from new services launched across England to help […]
NHS Launches Online Service to Find Nearest Walk-in Jab Site
The NHS COVID-19 Vaccination programme, the biggest in health service history, today launched a new […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more